Skip to main content
OpenTrials
Completed

NCT Number: NCT01139879

P400 for Stage II-IV Pressure Ulcers in Home and Extended Care

To assess the efficacy of a pressure ulcer treatment mattress, the P400 mattress, in the treatment of multiple Stage II or one or more large Stage III or IV pressure ulcers in the home care and extended care (nursing home) environment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Southwest Regional Wound Care Center

Lubbock, Texas, 79410, United States

About this study

Subjects will be recruited from those presenting to the wound clinic and meet the inclusion criteria. A total of 30 evaluable subjects will be recruited for this study from up to 2 wound care clinics /home health agencies (15 in Home Care and 15 in Extended Care). Subjects will be followed by weekly wound assessments for a period of 12 weeks or until their wounds heal. The outcome measurement is the rate of healing over the 12 week period.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject has multiple Stage II pressure ulcers or at least one Stage III or IV pressure ulcer(s) (as per National Pressure Ulcer Advisory Panel Staging guidelines) located either on the trunk or pelvis (which would include trochanter and ischial ulcers ) having a clean wound bed of less than or equal to 25% necrotic tissue at the base of the pressure ulcer.
  • Subjects may have heel ulcers, however these ulcers may not be considered a target study ulcer.
  • Subject, or legally authorized representative is able to provide informed consent
  • Subject weighs between 70 and 350 pounds
  • Subject's nutritional status is thought to be adequate to support wound healing
  • Subject qualifies for a Group 2 support surface (Target study ulcer must be at least 8 cm^2 in area to qualify)

Exclusion criteria

  • Subject's target ulcer is unstageable due to eschar or necrosis or a suspected Deep Tissue Injury may be located at the base of the wound.
  • Subject has unresolved systemic infection, or pressure ulcer infection, or a history of osteomyelitis, or greater than 25% eschar or necrotic tissue present in the wound bed.
  • Patient has already been enrolled in this study
  • Patient has a recent history of non-compliance with pressure ulcer offloading, repositioning, or other areas of the treatment care plan, which would jeopardize wound healing if continued.
  • Care plan goals are palliative

Treatment and study plan

P400 mattress

Device

The P400 mattress will be placed for a period of 12 weeks.

Primary outcomes

  1. Change From Baseline in Ulcer Surface Area at Week 12

    Time frame: 12 Weeks

    The primary outcome measure for this study is to be healing rate by area, based on the identified target study ulcer.

Secondary outcomes

  1. Incidence of New Ulcers

    Time frame: 12 Weeks

    incidence of new ulcers while on the study surface

  2. Healing Rate Per Week

    Time frame: 12 weeks

    The mean change in area per week for all ulcers

Sponsors and collaborators

Lead sponsor

Hill-Rom

Industry

Registry information

Official study title

Assessment of the Incidence and Treatment of Stage II -IV Pressure Ulcers in the Home Care or Extended Care Environments Utilizing the P400 Mattress

Acronym: P400

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Jun 9, 2010
Registry last updated
Dec 17, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.